We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




A Chemical in Red Wine, Fruits and Vegetables Stops Cancer

By HospiMedica staff writers
Posted on 13 Nov 2007
A new study has found that very high doses of antioxidant polyphenols--commonly found in red wine, fruits, vegetables, and green tea--shut down cancerous tumors by cutting off the formation of new blood vessels needed for their growth. More...


Researchers at the University of Angers (France) investigated the effects of polyphenols on postischemic neovascularization. Rats treated with low doses of red wine polyphenolic compounds were submitted to femoral artery ligature on the left leg. The researchers found that at relatively low doses, polyphenols play a beneficial role for those with diseased hearts and circulatory systems by facilitating blood vessel growth. The amount of polyphenols necessary for this effect was found to be the equivalent of only one glass of red wine per day or simply sticking to a healthy diet of fruits and vegetables containing polyphenols.

However, according to the authors, the amount of polyphenols necessary to obtain an anti-cancer effect is the equivalent of drinking about a bottle of red wine each day. This amount of daily alcohol consumption obviously is unhealthy, but the researchers suggest that polyphenols extracted from plants or red wine could be converted into a pill form that is highly likely to be safe. Such a pill also would be relatively easy and inexpensive to create and deliver. The study was published in the November 2007 issue of The Federation of American Societies for Experimental Biology (FASEB) Journal.

"The use of plant polyphenols as therapeutic tools presents important advantages,” said lead author Daniel Henrion, Ph.D., "because they have a good safety profile, a low cost and they can be obtained everywhere on the planet.”

This study also adds to a growing body of research showing dose-dependent relationships for many types of commonly used compounds; for instance, research published in the October 2006 issue of The FASEB Journal showed that aspirin, through different mechanisms, also has a dose-dependent relationship for heart disease and cancer.


Related Links:
University of Angers

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.